1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2014

Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2014" provides data on the Bipolar Disorder (Manic Depression) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bipolar Disorder (Manic Depression). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bipolar Disorder (Manic Depression). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Bipolar Disorder (Manic Depression) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Bipolar Disorder (Manic Depression) 25
Subjects Recruited Over a Period of Time 32
Clinical Trials by Sponsor Type 33
Prominent Sponsors 34
Top Companies Participating in Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials 35
Prominent Drugs 37
Latest Clinical Trials News on Bipolar Disorder (Manic Depression) 38
Mar 31, 2014: Forest Laboratories and Gedeon Richter Announce Positive Phase IIb Topline Results for Cariprazine for the Treatment of Bipolar Depression 38
Clinical Trial Profiles 39
Clinical Trial Overview of Top Companies 39
AstraZeneca PLC 39
Clinical Trial Overview of AstraZeneca PLC 39
Eli Lilly and Company 44
Clinical Trial Overview of Eli Lilly and Company 44
Pfizer Inc. 47
Clinical Trial Overview of Pfizer Inc. 47
Johnson and Johnson 50
Clinical Trial Overview of Johnson and Johnson 50
Otsuka Holdings Co., Ltd. 53
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 53
GlaxoSmithKline plc 56
Clinical Trial Overview of GlaxoSmithKline plc 56
Abbott Laboratories 58
Clinical Trial Overview of Abbott Laboratories 58
Merck and Co., Inc. 60
Clinical Trial Overview of Merck and Co., Inc. 60
Bristol-Myers Squibb Company 62
Clinical Trial Overview of Bristol-Myers Squibb Company 62
Novartis AG 64
Clinical Trial Overview of Novartis AG 64
Clinical Trial Overview of Top Institutes / Government 66
National Institute of Mental Health 66
Clinical Trial Overview of National Institute of Mental Health 66
Massachusetts General Hospital 69
Clinical Trial Overview of Massachusetts General Hospital 69
University of Pittsburgh 72
Clinical Trial Overview of University of Pittsburgh 72
U.S. Department of Veterans Affairs 73
Clinical Trial Overview of U.S. Department of Veterans Affairs 73
Mclean Hospital 74
Clinical Trial Overview of Mclean Hospital 74
University of Texas Southwestern Medical Center at Dallas 75
Clinical Trial Overview of University of Texas Southwestern Medical Center at Dallas 75
University of Cincinnati 76
Clinical Trial Overview of University of Cincinnati 76
University of British Columbia 77
Clinical Trial Overview of University of British Columbia 77
University Hospitals of Cleveland 78
Clinical Trial Overview of University Hospitals of Cleveland 78
Lindner Center of HOPE 79
Clinical Trial Overview of Lindner Center of HOPE 79
Five Key Clinical Profiles 80
Appendix 157
Abbreviations 157
Definitions 157
Research Methodology 158
Secondary Research 158
About GlobalData 159
Contact Us 159
Disclaimer 159
Source 159

List of Tables
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Region, 2014* 7
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Bipolar Disorder (Manic Depression) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Bipolar Disorder (Manic Depression) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Bipolar Disorder (Manic Depression) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Bipolar Disorder (Manic Depression) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Bipolar Disorder (Manic Depression) Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Bipolar Disorder (Manic Depression) Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Bipolar Disorder (Manic Depression) Therapeutics, Global, Terminated Clinical Trials, 2014* 28
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 32
Bipolar Disorder (Manic Depression) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 33
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 34
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 36
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 37
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 39
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 44
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 47
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2014* 50
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2014* 53
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 56
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 58
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2014* 60
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 62
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 64
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014* 66
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 69
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014* 72
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 73
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mclean Hospital, 2014* 74
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Southwestern Medical Center at Dallas, 2014* 75
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cincinnati, 2014* 76
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of British Columbia, 2014* 77
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals of Cleveland, 2014* 78
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Lindner Center of HOPE, 2014* 79

List of Figures
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Bipolar Disorder (Manic Depression) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Bipolar Disorder (Manic Depression) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Bipolar Disorder (Manic Depression) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Bipolar Disorder (Manic Depression) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 32
Bipolar Disorder (Manic Depression) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 33
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 34
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 35
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 37
GlobalData Methodology 158

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.